MetLife Investment Management’s Embecta EMBC Stock Holding History

MetLife Investment Management’s Portfolio EMBC Stock Details EMBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$115K	Buy	35,333 +2,165	+7%	+$11.8K	﹤0.01%	2722
2026 Q1	$293K	Hold	33,168	–	–	﹤0.01%	2015
2025 Q4	$394K	Sell	33,168 -1,377	-4%	-$18.2K	﹤0.01%	1908
2025 Q3	$487K	Hold	34,545	–	–	﹤0.01%	1820
2025 Q2	$335K	Hold	34,545	–	–	﹤0.01%	1889
2025 Q1	$440K	Sell	34,545 -617	-2%	-$9.88K	﹤0.01%	1787
2024 Q4	$726K	Sell	35,162 -315	-0.9%	-$5.16K	﹤0.01%	1585
2024 Q3	$500K	Hold	35,477	–	–	﹤0.01%	1783
2024 Q2	$443K	Buy	35,477 +5,032	+17%	+$61.1K	﹤0.01%	1788
2024 Q1	$404K	Hold	30,445	–	–	﹤0.01%	1793
2023 Q4	$576K	Hold	30,445	–	–	﹤0.01%	1603
2023 Q3	$458K	Hold	30,445	–	–	﹤0.01%	1691
2023 Q2	$658K	Hold	30,445	–	–	﹤0.01%	1515
2023 Q1	$856K	Hold	30,445	–	–	0.01%	1306
2022 Q4	$770K	Hold	30,445	–	–	0.01%	1357
2022 Q3	$877K	Hold	30,445	–	–	0.01%	1264
2022 Q2	$771K	Buy	+30,445	New	+$877K	0.01%	1360

Other funds holding EMBC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

MetLife Investment Management's EMBC Position: Q2 2026 in Review

MetLife Investment Management increased its Embecta (EMBC) stake by 6.5% in Q2 2026, buying an estimated $11.8K and bringing the position to 35,333 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

MetLife Investment Management first reported a position in EMBC in Q2 2022 and has held it in 17 quarters since. The position peaked at $877K in Q3 2022. 322 funds tracked by Wall St. Rank hold EMBC as of Q2 2026.

MetLife Investment Management held 35,333 shares of Embecta worth $115K as of Q2 2026.
MetLife Investment Management bought 2,165 Embecta shares in Q2 2026, an estimated $11.8K.
Embecta made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2722 holding.
MetLife Investment Management first reported a position in Embecta in Q2 2022 and has held it in 17 quarters since.
MetLife Investment Management's Embecta position peaked at $877K in Q3 2022.
322 funds tracked by Wall St. Rank held Embecta as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.